Редактирование: CDR2

Cerebellar degeneration-related protein 2 (Major Yo paraneoplastic antigen) (Paraneoplastic cerebellar degeneration-associated antigen) [PCD17]

==Publications==

{{medline-entry
|title=Neuro-degeneration profile of Alzheimer's patients: A brain morphometry study.
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/28459000
|abstract=Alzheimer's disease (AD) is a primary and progressive neurodegenerative disorder, which is marked by cognitive deterioration and memory impairment. Atrophy of hippocampus and other basal brain regions is one of the most predominant structural imaging findings related to AD. Most studies have evaluated the pre-clinical and initial stages of AD through clinical trials using Magnetic Resonance Imaging. Structural biomarkers for advanced AD stages have not been evaluated yet, being considered only hypothetically. To evaluate the brain morphometry of AD patients at all disease stages, identifying the structural neuro-degeneration profile associated with AD severity. AD patients aged 60 years or over at different AD stages were recruited and grouped into three groups following the Clinical Dementia Rating (CDR) score: [[CDR1]] (n = 16), [[CDR2]] (n = 15), CDR3 (n = 13). Age paired healthy volunteers (n = 16) were also recruited (control group). Brain images were acquired on a 3T magnetic resonance scanner using a conventional Gradient eco 3D T1-w sequence without contrast injection. Volumetric quantitative data and cortical thickness were obtained by automatic segmentation using the Freesurfer software. Volume of each brain region was normalized by the whole brain volume in order to minimize age and body size effects. Volume and cortical thickness variations among groups were compared. Atrophy was observed in the hippocampus, amygdala, entorhinal cortex, parahippocampal region, temporal pole and temporal lobe of patients suffering from AD at any stage. Cortical thickness was reduced only in the parahippocampal gyrus at all disease stages. Volume and cortical thickness were correlated with the Mini Mental State Examination (MMSE) score in all studied regions, as well as with CDR and disease duration. As previously reported, brain regions affected by AD during its initial stages, such as hippocampus, amygdala, entorhinal cortex, and parahippocampal region, were found to be altered even in individuals with severe AD. In addition, individuals, specifically, with CDR 3, have multiple regions with lower volumes than individuals with a CDR 2. These results indicate that rates of atrophy have not plateaued out at CDR 2-3, and in severe patients there are yet neuronal loss and gliosis. These findings can add important information to the more accepted model in the literature that focuses mainly on early stages. Our findings allow a better understanding on the AD pathophysiologic process and follow-up process of drug treatment even at advanced disease stages.
|mesh-terms=* Aged
* Aged, 80 and over
* Alzheimer Disease
* Atrophy
* Brain
* Brain Mapping
* Female
* Humans
* Male
* Neurodegenerative Diseases
* Organ Size
|keywords=* Aging
* Alzheimer's disease
* Brain atrophy
* Cortical thickness
|full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5397580
}}
{{medline-entry
|title=Somatic hypermutation leads to diversification of the heavy chain immunoglobulin repertoire in cattle.
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/22070825
|abstract=The availability of unique variable (VH), diversity (D), and joining (JH) gene segments in the vertebrate germline determines the extent to which a primary immunoglobulin (Ig) repertoire can be generated through combinatorial rearrangement. Although bovine D segments possess unusual properties, the diversity of the primary Ig heavy chain (IgH) repertoire in cattle is restricted by the dominance of a single family of germline VH genes of limited number and diversity. Cattle therefore must employ other diversification strategies in order to generate a functional IgH repertoire, the main candidates being gene conversion and somatic hypermutation. In considering these possibilities, we predicted that if somatic hypermutation was active during B lymphocyte development, the process would introduce nucleotide substitutions to the VDJ exon and also non-coding region lying downstream of the rearranged JH segment. In contrast, our expectation was that gene conversion would show a greater tendency to confine modification to the IgH coding sequence, leaving intron regions substantially unmodified. An analysis of rearranged IgH sequences from cattle of different ages revealed that the diversification of germline sequences could be observed in very young calves and that substitution frequency increased with age. The age-dependent accumulation of mutations was particularly apparent in the second IgH complementarity-determining region ([[CDR2]]). Single base substitutions were found to predominate, with purines targeted more frequently than pyrimidines and transitions favoured over transversions. In non-coding regions, mutations were detected at a normalised frequency that was indistinguishable from that observed in [[CDR2]]. These data are consistent with a process of IgH diversification driven predominantly by somatic hypermutation.
|mesh-terms=* Aging
* Animals
* Base Sequence
* Cattle
* Immunoglobulin Heavy Chains
* Immunoglobulin Variable Region
* Molecular Sequence Data
* Polymerase Chain Reaction
* Sequence Analysis, DNA
* Somatic Hypermutation, Immunoglobulin
* VDJ Exons

|full-text-url=https://sci-hub.do/10.1016/j.vetimm.2011.10.001
}}
{{medline-entry
|title=Synthetic autoantigens of immunoglobulins and T-cell receptors: their recognition in aging, infection, and autoimmunity.
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/7938045
|abstract=Immunoglobulins and their close relatives, the antigen-specific T-cell receptors, are recognition proteins that express structures which readily serve as self-immunogens. Healthy humans can produce antibodies against variable region-defined recognition structures termed idiotypes, as well as against constant region structures, and the levels of these can increase markedly in autoimmune disease; e.g., rheumatoid factors are autoantibodies directed against a conformational determinant of the gamma heavy chain. More recent analyses employing synthetic peptide technologies and construction of recombinant T-cell receptors document that autoantibodies directed against both variable and constant region markers of the alpha/beta T-cell receptor occur in healthy individuals. Alterations in levels of antibody, usage of IgM or IgG isotypes, and specificity for particular peptide-defined regions vary with natural physiological processes (aging, pregnancy), with artificial allografting, with retroviral infection, and with the inception and progression of autoimmune disease (e.g., rheumatoid arthritis, systemic lupus erythematosus). Two of the major autoimmunogeneic regions of the Tcr alpha/beta are "constitutive" markers inasmuch as all individuals tested produce antibodies against these regions. The most frequently observed autoantibodies are against Tcr V beta [[CDR1]] and Fr3 markers. It is hypothesized that these are normally involved in immunoregulation. Autoantibodies usually are not detected against [[CDR2]] region determinants, or the "private idiotypes" defined by the CDR3 region, or the highly conserved FR4 segment specified by the joining gene segment. However, autoantibodies against the [[CDR2]] of the Tcr alpha chain occur in some SLE patients, and healthy pregnant women produce antibodies against the common peptide determinant expressed by the joining gene and the beginning of the C alpha or C beta domain. Although the precise role of the naturally occurring autoantibodies in immunoregulation remains to be determined, modification of the course of autoimmune diseases in experimental rodent models (experimental allergic encephalomyelitis) has been successfully carried out by immunization with synthetic peptides corresponding to the [[CDR2]] and Fr3/CDR3 segments, and immunization of humans with synthetic V beta [[CDR2]] segments may prove helpful in multiple sclerosis. Moreover, infusion of intravenous immunoglobulins has been successful in the treatment of many autoimmune diseases, including examples where levels of T cells bearing particular V beta gene subsets were elevated. The recent knowledge gained from T-cell receptor structural analysis and antigenic modeling holds promise for determining the roles of particular variable domain structures in antigen recognition MHC-restriction and immunoregulation, and in the development of synthetic and recombinant reagents for modulation of autoimmune and infectious diseases.
|mesh-terms=* Aging
* Amino Acid Sequence
* Animals
* Autoantibodies
* Autoantigens
* Autoimmunity
* Epitope Mapping
* Humans
* Immunoglobulins
* Models, Molecular
* Molecular Sequence Data
* Peptide Fragments
* Receptors, Antigen, T-Cell
* Retroviridae Infections

|full-text-url=https://sci-hub.do/10.3181/00379727-207-43801
}}
{{medline-entry
|title=Increased severity of experimental autoimmune encephalomyelitis in rats tolerized as adults but not neonatally to a protective TCR V beta 8 [[CDR2]] idiotope.
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/7529291
|abstract=The ability of synthetic V region peptides to induce regulatory T cells and Abs in rodents and humans provides clear evidence that these idiotopes do not naturally induce tolerance. In this study, we investigated the ability of TCR V beta 8.2 peptides to experimentally induce specific T cell tolerance, as measured by loss of Ag-specific proliferation and delayed-type hypersensitivity responses, and by increased susceptibility to experimental autoimmune encephalomyelitis (EAE). We found that both neonatal and adult exposure to V beta 8.2-39-59 or V beta 8-44-54 peptides could induce efficient T cell tolerance, resulting in a significant inhibition of peptide-specific proliferative responses. In addition, neonatal tolerance resulted in a partial reduction in delayed-type hypersensitivity response and an inability to vaccinate against EAE after adult immunization with the tolerizing peptide. We further evaluated the contribution of naturally induced TCR-specific responses to EAE resistance induced by challenging neonatally or adult tolerized rats with myelin basic protein in adjuvant. The clinical course of EAE was not significantly altered in rats tolerized neonatally to V beta 8.2 peptides, but both the severity and incidence of mortality from EAE was increased in rats tolerized as adults with V beta 8.2 peptides conjugated to syngeneic splenocytes. These results demonstrate that V beta 8.2 peptides are tolerogenic as well as immunogenic. Moreover, the observation of different effects of neonatal vs adult tolerization on the course of EAE suggests either the emergence of additional protective idiotopes after neonatal tolerization and/or mechanistic differences in the two tolerance-inducing protocols. Most importantly, the enhancement of clinical EAE in rats tolerized as adults with V beta 8.2 peptides provides evidence for an innate regulatory role of the [[CDR2]] idiotope in recovery from EAE.
|mesh-terms=* Aging
* Amino Acid Sequence
* Animals
* Animals, Newborn
* Encephalomyelitis, Autoimmune, Experimental
* Enzyme-Linked Immunosorbent Assay
* Epitopes
* Immune Tolerance
* Immunization
* Lymphocyte Activation
* Molecular Sequence Data
* Rats
* Rats, Inbred Lew
* Receptors, Antigen, T-Cell, alpha-beta
* Severity of Illness Index


}}
{{medline-entry
|title=Monoclonal antibodies reactive with subsets of mouse and human thymic epithelial cells.
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/2461413
|abstract=We describe monoclonal antibodies (MAB) reactive with subsets of mouse and human thymic epithelial cells. Rat MAb [[CDR1]] reacts with mouse but not human cortical epithelial cells. Immunologic staining of thymic nurse cells in suspension indicates the [[CDR1]] antigen is located on the cell surface. Mouse MAb [[CDR2]] reacts with human but not mouse cortical thymic epithelial cells. Rat MAb MD1 and MD2 detect different determinants expressed by most medullary epithelial cells in mouse thymus but fewer such cells in human thymus. In addition, MD1 detects flattened subcapsular cells rarely in mouse thymus but frequently in human thymus. Two-color stains using an anti-keratin antiserum demonstrate the epithelial nature of the cells reactive with these antibodies. The antigens detected by [[CDR1]] and MD1 first appear during the neonatal period, achieving adult distribution by postnatal days 14 and 4, respectively. The extra-thymic staining of these MAb is described. On the basis of their intra- and extra-thymic reactivities, these MAb differ from those previously reported and may permit dissection of the thymic microenvironment.
|mesh-terms=* Aging
* Animals
* Animals, Newborn
* Antibodies, Monoclonal
* Antigens, Surface
* Epithelium
* Histocytochemistry
* Humans
* Immunoenzyme Techniques
* Keratins
* Male
* Mice
* Mice, Inbred AKR
* Mice, Inbred BALB C
* Mice, Inbred C57BL
* Rats
* Thymus Gland

|full-text-url=https://sci-hub.do/10.1177/36.12.2461413
}}